Holder snapshot 7 signals
Share change
+28,745,652
Put/Call ratio
40%
SEC-reported price per share
$0.92
Number of holders
85
Value change
+$26,555,200
Number of buys
56
Open additional details 1 more signal available
Number of sells
20
Security identity Names, identifiers, and filing context for this profile. 1 source field
Shares outstanding
1,571,428,571

Security key

00653A107

Report period

Q2 2023

Institutions

85

Top holders

10

Ownership snapshot

Top reported holders of ADAPY - Adaptimmune Therapeutics PLC - American Depositary Shares, each representing 6 Ordinary Shares (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader
Matrix Capital Management...
Disclosed value leader
Matrix Capital Management...
Comparable rows
0/15
Latest evidence
31 Mar 2023
13F Highest disclosed value: $42,481,862 15 rows are not safely comparable across share classes. Showing 1-6 of 15 holder rows.

Quick read

Matrix Capital Management Company, LP has the largest disclosed position value at $42.48M.

0 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens Matrix Capital Management Company, LP's linked filing trail.
Disclosed position value Top 5
Matrix Capital Management Company... $42.48M
BAILLIE GIFFORD & CO $18.65M
NEA Management Company, LLC $18.62M
BAKER BROS. ADVISORS LP $10.72M
PFM Health Sciences, LP $6.53M

Value bars compare disclosed positions; verify each figure against the linked filing evidence.

Detailed SEC evidence table Showing 1-6 of 15 holder rows
Holder Evidence Ownership % Position 12M Net Δ As of
Matrix Capital Management Company, LP
13F
Company
13F
—
denominator unverified
$42,481,862
38,974,185 shares
— 31 Mar 2023
BAILLIE GIFFORD & CO
13F
Company
13F
—
denominator unverified
$18,652,082
17,112,002 shares
— 31 Mar 2023
NEA Management Company, LLC
13F
Company
13F
—
denominator unverified
$18,616,958
17,079,779 shares
— 31 Mar 2023
BAKER BROS. ADVISORS LP
13F
Company
13F
—
denominator unverified
$10,715,656
9,830,877 shares
— 31 Mar 2023
PFM Health Sciences, LP
13F
Company
13F
—
denominator unverified
$6,531,902
5,992,571 shares
— 31 Mar 2023
Long Focus Capital Management, LLC
13F
Company
13F
—
denominator unverified
$5,924,629
5,435,439 shares
— 31 Mar 2023
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q2 2023

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions
85
Shares
144,690,313
Rows available
85
Investor Option Weight % Change % SEC-reported value * Price Shares Share Change Activity Report Period

* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q2 2023 vs Q1 2023 Across Filers

Q1 2023 holders
62
Q2 2023 holders
85
Holder diff
23
Investor Q1 2023 Shares Q2 2023 Shares Share Diff Share Chg % Q1 2023 value Q2 2023 value Value change Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .